TWTri Yunis Miko Wahyono

Tri Yunis Miko Wahyono

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tri Yunis Miko Wahyono has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of BMI on Mortality in Patients With Tuberculosis and HIV Coinfection in Asia and Africa: Systematic Review and Meta-Analysis

    by Mufti As Siddiq M Irzal, Tri Yunis Miko Wahyono, Putri Novia Choiri Insani, Welstin Wemi Loa, Leopardo Alvalius Ngetwa

    Background: Tuberculosis (TB) continues to pose a major global health threat, particularly in low- and middle-income countries. An estimated 10.8 million people developed TB in 2023, corresponding to 134 cases per 100,000 population. The Southeast Asia region accounted for 45% of global TB incidence, while the African region contributed 24%. Nutritional status, particularly low BMI, is a key modifiable determinant of adverse clinical outcomes. However, its overall impact on mortality among TB-HIV coinfected populations in Asia and Africa remains poorly quantified. Objective: This study aimed to systematically assess the association between BMI and mortality among patients with TB-HIV coinfection in Asia and Africa. Methods: A systematic review and meta-analysis were conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. Cohort studies published between 2000 and 2024 were identified through PubMed, Scopus, and ProQuest. Data extraction and risk of bias assessment were performed independently by 3 reviewers using the Risk of Bias in Non-Randomized Studies – of Exposure tool. A random effects model with the DerSimonian-Laird method was applied using RevMan 7.2 (Cochrane) to estimate pooled risk ratios with 95% CI. Heterogeneity was quantified using the I ² statistic, and subgroup analyses were conducted by geographic region. Results: Seven cohort studies met the inclusion criteria. The pooled estimate indicated that patients with BMI less than 18.5 kg/m² had approximately twofold higher mortality risk compared to those with normal or higher BMI (risk ratio=2.01; 95% CI 1.63‐2.48; P <.001). Despite moderate heterogeneity ( I ²=64%), the association remained consistent across subgroups. Although most studies were rated as having high or moderate risk of bias, sensitivity analyses confirmed the robustness of the results. Conclusions: Low BMI significantly increases the risk of mortality among patients with TB and HIV coinfection in Asia and Africa, underscoring its prognostic and modifiable role in clinical outcomes. Routine nutritional screening, BMI monitoring, and targeted supplementation should be integrated into national TB-HIV management programs, particularly in resource-limited settings. Strengthening TB-HIV nutrition service integration is essential to improve survival and achieve global End TB and United Nations Programme on HIV/AIDS 95-95‐95 targets.

  • A CASE CONTROL STUDY: DETERMINANTS OF QUALITY OF LIFE FOR INDIVIDUALS LIVING WITH SCHIZOPHRENIA IN GORONTALO, INDONESIA

    by Sirajuddien Bialangi, Tri Yunis Miko Wahyono, Helda, Syahrizal Syarif, Hervita Diatri, Kholisotul Hikmah

    Quality of life (QOL) has consistently been a significant consideration regarding the impact of mental illnesses, particularly schizophrenia. Despite this, relatively few studies have measured QOL in this population, with most focusing on patients in hospital settings. This study intends to examine the factors associated with QOL among individuals living with schizophrenia who are receiving treatment in primary health care facilities (puskesmas) in Gorontalo, Indonesia. A case-control study was conducted to investigate QOL as the outcome measure. The cases comprised individuals aged 18 and above living with schizophrenia who reported a poor QOL, while the controls were individuals with schizophrenia, but who reported a good QOL. To assess the risk factors associated with QOL among this population, a multivariate logistic regression analysis was employed. Among the 116 subjects in the study, the majority were men aged 36 to 45, with many being single and unemployed; in contrast, most of the controls were employed. Both groups primarily consisted of individuals with no reported monthly income. Findings indicated that lower educational attainment (aOR = 7.92; 95% CI = 1.28 – 48.98), being single (aOR = 5.50; 95% CI = 1.56 – 19.41), and lacking a monthly income (aOR = 4.82; 95% CI = 1.67 – 13.94) significantly increased the risk of poor QOL. As a conclusion, the study underscores the importance of addressing educational level, marital status, and income in improving QOL for individuals with schizophrenia and suggests a focus on supporting single individuals with lower education and absent income in public health initiatives.

  • Open Access

    Effect of Body Mass Index on Mortality in Patients with Tuberculosis and HIV Co-Infection within the Scope of Asia Africa: A Systematic Review and Meta-Analysis (Preprint)

    by Mufti As Siddiq M Irzal, Tri Yunis Miko Wahyono, Putri Novia Choiri Insani, Welstin Wemi Loa, Leopardo Alvalius Ngetwa

    BACKGROUND In 2022, an estimated 10.6 million people developed tuberculosis (TB) globally, with 6.3% co-infected with HIV. The Southeast Asia region accounted for 46% of global TB cases, while Africa contributed 23%. TB-HIV co-infection remains a major cause of death, with 167,000 deaths recorded among co-infected individuals in 2022. Nutritional status, particularly Body Mass Index (BMI), may influence mortality in this population. However, no comprehensive synthesis of the evidence currently exists. OBJECTIVE To assess the association between BMI and mortality among TB-HIV co-infected patients in Asia and Africa. METHODS A systematic review and meta-analysis of cohort studies published between 2000 and 2024 were conducted using PubMed, Scopus, and ProQuest. A random-effects model was applied to calculate pooled Risk Ratio (RR) and 95% confidence intervals. RESULTS Eleven cohort studies met the inclusion criteria. Patients with low BMI (<18.5 kg/m²) had a 10% higher risk of mortality compared to those with normal or higher BMI (RR = 0.90; 95% CI: 0.86–0.94; p < 0.05). Heterogeneity was substantial (I² = 78%), but the association remained statistically significant and robust. CONCLUSIONS Low BMI is significantly associated with increased mortality among TB-HIV co-infected patients in Asia and Africa. Routine nutritional screening and targeted support should be prioritized in TB-HIV clinical management strategies. CLINICALTRIAL This systematic review and meta-analysis has been registered with the Open Science Framework (doi: 10.17605/OSF.IO/74QWH).

  • Improving the effectiveness of DHF prevention: Lessons from Pariaman City

    by Harisnal, Tri Yunis Miko Wahyono, Ratna Djuwita, Dewi Susanna, Cici Apriza Yanti

    Background: The Aedes aegypti mosquito transmits the viral disease dengue hemorrhagic fever (DHF), a significant public health problem in many tropical countries. The 1 House 1 Larva Monitoring (G1R1J) Movement, which involves every household as a mosquito larva monitoring agent, is one of the efforts to help communities control mosquito growth. Dengue Hemorrhagic Fever (DHF), transmitted by the Aedes aegypti mosquito, remains a significant public health issue in many tropical regions. The “1 House 1 Larva Monitoring” (G1R1J) movement, which mobilizes households as mosquito larvae monitoring agents, represents a community-based approach to controlling mosquito proliferation. Objective: This study highlights a knowledge gap regarding the effectiveness of the G1R1J program with larvae-monitoring students compared to a program solely relying on larva-monitor cadres. This study addresses a knowledge gap by comparing the effectiveness of the G1R1J program integrated with larva-monitoring students against the traditional approach relying solely on larva- monitor cadres. Materials and methods: This study used a comparative design to compare the efficiency of the G1R1J program with the number of DHF cases in two DHF-endemic areas in Pariaman City, West Sumatra. A comparative study was designed to evaluate the efficiency of the G1R1J program concerning the incidence of DHF cases in two endemic areas in Pariaman City, West Sumatra. The researchers focused on field surveys and community attitudes because these aspects are directly linked to the implementation and success of the G1R1J program. Results: The main results, with p=0.000 and OR 0.03, showed that comprehensive field-based interventions can significantly reduce the risk of vector presence. The study also demonstrated the importance of community attitudes in vector control, with p=0.002 and OR=0.15, suggesting that positive attitudes towards vector control practices can enhance the program’s effectiveness. Statistical analysis revealed significant results, with a p-value of 0.000 and an odds ratio (OR) of 0.03, indicating that comprehensive, field-based interventions markedly reduce vector presence. Additionally, the study highlighted the role of community attitudes, with p=0.002 and OR=0.15, underscoring that positive perceptions and practices towards vector control significantly enhance program effectiveness. Conclusion: This study shows that integrating the G1R1J program with larvamonitoring students can reduce the density of Aedes Aegypti mosquito vectors and dengue fever incidence. In addition, it offers strategic guidance for building more sustainable and efficient vector control policies in other endemic areas. Integrating the G1R1J program with larvae-monitoring students reduces Aedes aegypti vector density and DHF incidence. This approach offers strategic insights for developing sustainable and efficient vector control policies in other endemic regions.


  • Open Access

    Spatial study of the implementation of ivermectin, diethylcarbamazine citrate, and albendazole in an urban area

    by Ikrimah Nafilata, Taniawati Supali, Tri Yunis Miko Wahyono, Nurhayati Adnan Prihartono, Kholisotul Hikmah, Yuli Puspita Devi

    Studies on lymphatic filariasis (LF) in Indonesia have mostly focused on the disease determinants with limited focus on spatial-based and the determinants of implementing ivermectin, diethylcarbamazine citrate, and albendazole (IDA). This study aimed to identify the causes of program failure. A cross-sectional survey was conducted from November to December 2022 in nine urban villages with high endemic records and one sentinel village in Pekalongan City, Central Java, Indonesia. The analysis using Quantum Geographical Information System (QGIS) and Pearson correlation. Slum settlements were linked to the presence of open sewers (p=0.000; r=0.974) and overcrowding (p=0.033; r=0.672), while the first round of IDA medication adherence correlated with knowledge of medication (p=0.054; r=-0.623) and willingness to take the medication in the second round (p=0.051, r=0.603). Adverse effects of the treatment are strongly correlated with drug boredom from taking medication (p=0.003; r=0.828) and assistance from health workers (p=0.027; r=0.791). We identified gaps in slum settlements, open sewers, overcrowding and medication adherence, including low knowledge of medication, unwillingness to take second-round medication, adverse effects, and boredom with taking medication. We recommend effective strategies by engaging health education between health workers, local leaders, and private sectors as key to ensuring elimination program.

  • Open Access

    Seroepidemiological investigation of SARS-CoV-2 infection and risk factors in Indonesia before mass COVID-19 vaccination

    by Tri Ym. Wahyono, Renti Mahkota, Fajaria Nurcandra, Ansariadi Ansariadi, Atik C. Hidajah, Helda Helda, Fariani Syahrul, Indra Dwinata, Nurhayati Kawi

    At the onset of the coronavirus disease 2019 (COVID-19) pandemic in Indonesia, surveillance focused on finding and treating symptomatic cases. However, emerging evidence indicated that asymptomatic and pre-symptomatic individuals significantly contributed to viral transmission. This highlights the need for comprehensive surveillance to understand better the actual spread of SARS-CoV-2. Therefore, the aim of this study was to determine the seroprevalence of SARS-CoV-2 antibodies in the general population across Indonesia and identify risk factors associated with infection at the beginning of the pandemic. A cross-sectional survey was conducted across 17 provinces, 69 districts/cities, and 1,020 villages in Indonesia from December 22, 2020, to February 15, 2021. A multistage random sampling technique was employed. Serological testing using enzyme-linked immunosorbent assay (ELISA) was performed to detect anti-SARS-CoV-2. Complex sample analysis, adjusted for weights, was utilized to estimate the national seroprevalence and a generalized linear model with a binomial distribution was applied to identify risk factors. A total of 10,161 individuals were included in the final analysis, with the national seroprevalence being 14.8% (95% confidence interval (CI): 14.2–18.5). The prevalence was higher in females (16.8%; 95%CI: 12.5–22.3), individuals aged 46–59 years (18.6%; 95%CI: 14.2–24.0), and in urban areas (20.1%; 95%CI: 15.0–26.2). The highest prevalence was observed in North Maluku (35.6%; 95%CI: 29.3–42.5). Notably, 54.2% of seropositive individuals were asymptomatic, while 7.5% reported hypertension as a comorbidity. Factors associated with higher seroprevalence were being married (adjusted prevalence ratio (aPR): 1.47; 95%CI: 1.02–2.12), widow (aPR: 1.74, 95%CI: 1.01–3.00), and close contact with confirmed cases (aPR: 2.04; 95%CI: 1.52–2.73). This study revealed a COVID-19 prevalence significantly higher than official estimate in Indonesia, underscoring the need for improved surveillance system to more accurately track disease spread and to inform timely public health responses in the future.


  • Open Access

    COVID-19 Vaccination Booster Uptake Is Related to End of Pandemic Perception: Population-Based Survey in Four Provinces in Indonesia

    by Ahmad Watsiq Maula, Citra Indriani, Risalia Reni Arisanti, Vincentius Arca Testamenti, Catharina Yekti Praptiningsih, Rebecca Merril, Ansariadi, Tri Yunis Miko Wahyono, Atik Choirul Hidajah, Riris Andono Ahmad

    Global COVID-19 booster vaccination uptake has been low, particularly in low-middle-income countries (LMICs). However, studies on the determinants of COVID-19 booster vaccination remain limited, especially in LMIC settings. This study aims to describe the determinants of COVID-19 booster vaccination uptake in an LMIC context. We analyzed data from a cross-sectional survey that was conducted in September 2022 in four provinces in Indonesia. Participants (n=2,223) were recruited using multiple-stage cluster sampling. Multivariable logistic regression analysis was used to identify factors associated with booster vaccination status. The proportion of COVID-19 booster vaccination among fully vaccinated adults was 29.5%, while fear of transmission (12.4%) and perceived risk of getting a COVID-19 infection (33.5%) were low. Multivariable analysis showed that people living on Java Island (aOR: 2.45, 95% CI: 1.87-3.24), living in the urban area (aOR: 2.04, 95% CI: 1.60-2.61), being an employee in the formal sector (aOR: 3.99, 95% CI: 1.93 - 8.58), experiencing a side effect from previous vaccination (aOR: 1.71, 95% CI: 1.40-2.09), having a history of SARS-COV2 infection (aOR: 2.10, 95%CI: 1.27-3.50), having perception on the upcoming new wave of COVID-19 (aOR: 1.37, 95% CI: 1.07 -1.76), and believing the pandemic has not ended (aOR: 1.29, 95% CI: 1.01, 1.64) were associated with booster shot uptake. Low educational level (aOR: 0.6, 95% CI: 0.39-0.93) inhibited booster vaccination uptake. Current booster dose coverage was considerably lower than the primary vaccination dosage. The low booster vaccination uptake in four provinces was associated with a belief the pandemic has no longer, which might hinder the catch up of wide-population target coverage and COVID-19 control for reduced disease severity and hospitalization. Thus, efforts need to be prioritized in reaching the COVID-19 vulnerable population, which includes elderly and those with comorbidities.

  • Open Access

    Recent Findings in Malaria Emergence of Piperaquine-Resistant Plasmodium falciparum Genes in Malaria Endemic Areas of Indonesia: a Literature Review

    by Ayu Nurdiantika Sari, Tri Yunis Miko Wahyono, Ayleen Alicia Kosasih, Yoshida Aussiana Samosir, Rania Rifdah Taufiq, Inge Sutanto

    Background: In recent years, artemisinin and piperaquine (PPQ) resistance in the Greater Mekong Sub-region alarmed Southeast Asian countries, especially those relying on artemisinin- based combinations as antimalarial drugs. This study aims to review the current status of malaria research and examine the frequencies of piperaquine resistance in Plasmodium falciparum isolates originating from malaria-endemic areas in Indonesia. Methods: We undertook a review to identify empirical data on antimalarial piperaquine-inclusive artemisinin combination therapies (ACT) in Indonesia using studies conducted since 2015. Journal articles were searched using the keywords combination of malaria, piperaquine, Pfcrt, Pfmdr, Pfpm2, and Indonesia. The search was conducted in four databases. Trends in empirical data were summarised in a table and compared with emerging malaria prevalence and conditions in Indonesia. Results: Our study found that dihydroartemisinin-piperaquine (DHA-PPQ) is still effective in most area. Survey of PPQ resistance in regions using DHA-PPQ as the first-line treatment heavily depends on phenotypic tests of the given drug resistance. Molecular surveys exploring polymorphisms of Pfcrt, Pfmdr1, and Pfpm2 were not found. Conclusion: This study supports the use of dihydroartemisinin-piperaquine as the first-line antimalarial drug in malaria endemic areas of Indonesia. Further research examining efficacy is required to monitor piperaquine resistance in Indonesia.